Antithrombotic therapy in coronary artery disease patients with atrial fibrillation.

ABSTRACT:

Background

Coronary artery disease (CAD) and atrial fibrillation (AF) frequently coexist in clinical practice, making it challenging for the treating physician to choose anticoagulation and antiplatelet therapies. The aim of this study was to investigate antithrombotic strategies and assess related adverse outcomes in stable coronary artery disease (SCAD) and acute coronary syndrome (ACS) patients with AF when the CHA₂DS₂-VASc score was ≥2.

Methods

We performed a retrospective study and collected data from a computer-based patient record management system in Zhengzhou University People's Hospital in China. In total, 2978 patients with a hospital discharge diagnosis of CAD and concomitant AF who met the inclusion criteria were enrolled from January 1, 20

SUBMITTER: Wei L 

PROVIDER: S-EPMC7339421 | biostudies-literature | 2020 Jul

REPOSITORIES: biostudies-literature